Trazodone Cost in Minnesota (2026): Prices, Insurance, and Savings

How Much Does Trazodone Cost in Minnesota in 2026?
At a glance
- Average Minnesota cash price / approximately $10 per month (30-day supply, generic)
- Manufacturer list price / $40 per month for generic trazodone
- Minnesota Medicaid status / covered with prior authorization
- Standard dosing / 50 to 150 mg oral tablet, once at bedtime for insomnia
- Telehealth prescribing / legal and available statewide in Minnesota
- 503A compounding / permitted in Minnesota for patient-specific prescriptions
- Most common form / 50 mg, 100 mg, and 150 mg immediate-release tablets
- FDA approval year / 1981, originally for major depressive disorder
- DEA schedule / not a controlled substance
- Patent status / off-patent since 1986; multiple generics available
Minnesota Cash Prices for Trazodone in 2026
The average cash price for a 30-day supply of generic trazodone at Minnesota retail pharmacies sits around $10 in 2026. That figure covers the most common strengths (50 mg and 100 mg tablets). The manufacturer list price is roughly $40 per month, but competition among generic producers has compressed actual shelf prices to a fraction of that number.
Price Variation by Pharmacy Type
Prices vary by pharmacy. Large chain pharmacies in the Twin Cities metro area, including CVS, Walgreens, and Walmart, typically price 30 tablets of trazodone 50 mg between $4 and $15. Independent pharmacies in Greater Minnesota may charge slightly more due to lower purchasing volume. Costco and grocery-chain pharmacies (Hy-Vee, Cub Foods) often land at the lower end of this range.
How Trazodone Compares to Other Sleep Medications
Trazodone's cost profile is substantially lower than branded sleep agents. Suvorexant (Belsomra) carries a retail price exceeding $400 per month, and lemborexant (Dayvigo) lists near $350 per month 1. Even generic zolpidem, another commonly prescribed sleep aid, runs $15 to $25 per month in Minnesota. A 2017 analysis in the Journal of Clinical Sleep Medicine confirmed trazodone as one of the lowest-cost pharmacologic options for insomnia management 2.
Trazodone was originally FDA-approved for major depressive disorder in 1981 3. Its off-label use for insomnia now accounts for the majority of prescriptions. A prescribing survey published in JAMA Internal Medicine found that trazodone was the second most commonly prescribed medication for insomnia in the United States, trailing only zolpidem 4.
Minnesota Medicaid Coverage for Trazodone
Minnesota Medical Assistance (the state Medicaid program) covers generic trazodone, but prescribers must obtain prior authorization. This requirement applies to both the depression indication and the off-label insomnia use.
Prior Authorization Requirements
The prior authorization process in Minnesota typically requires documentation that the patient has a qualifying diagnosis (major depressive disorder, generalized anxiety disorder, or insomnia) and that non-pharmacologic interventions have been considered. The American Academy of Sleep Medicine recommends cognitive behavioral therapy for insomnia (CBT-I) as first-line treatment before pharmacotherapy 5. Minnesota Medicaid aligns with this guidance by requesting documentation of behavioral approaches before approving long-term trazodone.
Copay Structure Under Medical Assistance
Once approved, most Minnesota Medicaid enrollees pay $0 to $3 for a 30-day supply. MinnesotaCare enrollees, who fall in a slightly higher income bracket, may see copays of $1 to $5 depending on income tier. The Mendelson 2005 review in the Journal of Clinical Psychiatry documented trazodone's efficacy for primary insomnia at doses of 50 to 100 mg, which supports the clinical rationale behind Medicaid formulary inclusion 6.
Managed Care Organization Formularies
Minnesota Medicaid operates primarily through managed care organizations (MCOs) such as Blue Plus, HealthPartners, Hennepin Health, and UCare. Each MCO maintains its own formulary, but all four include generic trazodone. Formulary tier placement is typically Tier 1 (preferred generic), which carries the lowest copay bracket.
Insurance Coverage Across Minnesota Plans
Commercial insurance plans available through MNsure (Minnesota's health insurance marketplace) and employer-sponsored plans consistently cover generic trazodone. The drug's position as a low-cost, off-patent generic makes formulary exclusion rare.
Employer-Sponsored Plans
Most employer plans in Minnesota place trazodone on Tier 1. Typical copays range from $0 to $10 for a 30-day supply. A 2022 Kaiser Family Foundation survey found that the average Tier 1 generic copay across employer plans nationally was $11, and Minnesota plan copays fall in line with that benchmark 7.
Medicare Part D
Medicare Part D plans available in Minnesota cover trazodone on preferred generic tiers. Under the Inflation Reduction Act provisions effective since 2025, out-of-pocket drug costs for Medicare beneficiaries are capped at $2,000 annually 8. Trazodone, at $10 per month cash price, rarely pushes patients toward that cap on its own. The CMS Medicare Plan Finder tool lists multiple Part D plans in Minnesota with $0 copays for trazodone.
HealthPartners and Blue Cross Blue Shield of Minnesota
HealthPartners, one of Minnesota's largest insurers, lists trazodone on its preferred generic tier across all individual and group plans. Blue Cross Blue Shield of Minnesota similarly places all trazodone formulations on Tier 1. Both carriers require no prior authorization for generic trazodone prescribed for depression.
Discount Programs and Savings Cards
Even without insurance, several programs reduce trazodone costs below the $10 average in Minnesota.
Pharmacy Discount Cards
GoodRx, RxSaver, and SingleCare each list Minnesota prices for trazodone 50 mg (30 tablets) between $3 and $8 depending on the pharmacy. These prices are available to uninsured and underinsured patients with no eligibility restrictions. Discount card pricing is not insurance and does not count toward deductibles.
Minnesota-Specific Assistance Programs
Minnesota's Prescription Drug Assistance Program helps residents who lack prescription coverage and have incomes below 300% of the federal poverty level. Generic medications like trazodone often qualify for $0 copays through this program. The Minnesota Board of Pharmacy maintains a list of participating pharmacies statewide 9.
Manufacturer Pricing Context
Because trazodone is manufactured by multiple generic companies (Teva, Aurobindo, Sun Pharma, and others), there is no single manufacturer copay card as exists for branded medications. Competition among these manufacturers is the primary driver of the $10 average retail price. A 2019 study in Health Affairs found that generic drugs with four or more manufacturers typically see prices drop to 10% to 20% of the original brand price 10.
Compounded Trazodone in Minnesota
Compounded trazodone is legal in Minnesota through 503A pharmacies. These pharmacies create patient-specific formulations when a prescriber determines that a commercially available product does not meet a patient's needs (e.g., liquid formulation for patients who cannot swallow tablets, or a custom dose strength).
503A vs. 503B Compounding
Under FDA guidance, 503A pharmacies compound on a per-patient prescription basis, while 503B outsourcing facilities can produce larger batches without individual prescriptions 11. Minnesota licenses both types. For trazodone specifically, 503A compounding is the more common pathway because commercially available tablets cover most standard doses (50 mg, 100 mg, 150 mg, 300 mg).
Cost of Compounded Trazodone
Compounded trazodone formulations in Minnesota typically cost $20 to $50 per month, depending on the formulation type and pharmacy. Liquid suspensions and custom-dose capsules sit at the higher end. These costs are generally not covered by insurance unless medical necessity is documented and the insurer approves the compounded product.
When Compounding Makes Clinical Sense
Compounding is most appropriate for patients who need doses not available in standard tablet increments, patients with excipient sensitivities (certain dyes, lactose, gluten), or pediatric patients requiring liquid formulations. The FDA notes that compounded drugs are not evaluated for safety, efficacy, or quality in the same manner as FDA-approved products 12.
Telehealth Prescribing in Minnesota
Minnesota permits trazodone prescribing via telehealth. Because trazodone is not a controlled substance, it faces fewer telehealth prescribing restrictions than medications like zolpidem or benzodiazepines.
How Telehealth Prescribing Works
A licensed Minnesota prescriber (or a provider in a state with an active interstate medical licensure compact agreement) can evaluate a patient via video or audio visit and transmit a trazodone prescription electronically to any Minnesota pharmacy. The Minnesota Board of Medical Practice adopted permanent telehealth prescribing rules following the pandemic-era temporary authorities 13.
Cost Implications of Telehealth
Telehealth visits for trazodone management typically cost $50 to $150 for the consultation (or a standard copay if covered by insurance). Combined with the $10 monthly medication cost, the total annual cost of trazodone therapy obtained via telehealth in Minnesota ranges from $170 to $420. The American Telemedicine Association reported that telemedicine visits cost patients 19% less on average than comparable in-person visits 14.
HealthRX Telehealth Access
HealthRX offers telehealth evaluations for trazodone in Minnesota. Board-certified providers review medical history, current medications, and sleep patterns before prescribing. Prescriptions are sent directly to the patient's preferred Minnesota pharmacy.
Clinical Considerations That Affect Cost
Several clinical factors influence the total cost of trazodone therapy beyond the per-tablet price.
Dose Titration and Monitoring
Trazodone dosing for insomnia typically starts at 25 to 50 mg and may increase to 100 to 150 mg. For depression, doses range from 150 mg to 400 mg daily in divided doses 15. Higher doses cost proportionally more. A patient taking 200 mg nightly would use two 100 mg tablets per dose, doubling the monthly tablet count and the cash price.
Lab Work and Follow-Up
Baseline and periodic monitoring may include a metabolic panel and liver function tests, particularly in older adults. A 2014 review in Drugs & Aging highlighted that trazodone has a favorable safety profile in geriatric populations compared to benzodiazepines but recommended periodic monitoring for orthostatic hypotension and QTc prolongation 16. Lab work adds $50 to $200 per panel, though most insurance plans cover routine labs.
Drug Interactions
Trazodone is metabolized by CYP3A4 and, to a lesser extent, CYP2D6. Strong CYP3A4 inhibitors (ketoconazole, ritonavir) can increase trazodone plasma levels, potentially requiring dose reduction 17. Dose adjustments do not typically change the per-tablet cost but may affect the number of tablets used monthly. The FDA label warns against concurrent use with MAOIs and recommends caution with serotonergic agents due to serotonin syndrome risk 18.
How to Get the Lowest Price in Minnesota
A few practical steps can minimize trazodone costs in Minnesota.
Step 1: Check Your Insurance Formulary
Verify that your plan covers trazodone on a preferred tier. Call the number on your insurance card or check the plan's online formulary tool. Most Minnesota plans place trazodone at Tier 1 with copays of $10 or less.
Step 2: Compare Pharmacy Prices
Use GoodRx, RxSaver, or the HealthRX price comparison tool to check prices at pharmacies near you. Costco, Walmart, and Hy-Vee often have the lowest prices in Minnesota. Price differences of $5 to $10 between pharmacies are common.
Step 3: Ask About 90-Day Fills
Many insurers and pharmacies offer 90-day supplies at a reduced per-unit cost. A 90-day supply of trazodone 50 mg might cost $8 to $20 at retail, compared to $10 per 30-day fill (saving roughly $10 over three months). Mail-order pharmacies from HealthPartners and Blue Cross Blue Shield of Minnesota offer this option.
Step 4: Apply for Assistance If Uninsured
Minnesota residents without insurance can apply for MinnesotaCare (for incomes up to 200% of the federal poverty level) or explore county-based purchasing programs. The program administered through the Minnesota Department of Human Services provides prescription coverage that includes generic trazodone 19.
For depression specifically, the STAR*D trial (N=4,041) demonstrated that when first-line antidepressants fail, switching to a different agent (including trazodone at adequate doses) can achieve remission in an additional 25% of patients 20. This finding supports trazodone as a cost-effective alternative when other antidepressants are ineffective or cause intolerable side effects.
Frequently asked questions
›How much does Trazodone cost in Minnesota?
›Does Minnesota Medicaid cover Trazodone?
›Is compounded trazodone legal in Minnesota?
›Can I get Trazodone via telehealth in Minnesota?
›Which insurance plans cover Trazodone in Minnesota?
›What's the cheapest way to get Trazodone in Minnesota?
›Are there Minnesota Trazodone discount programs?
›How does a generic savings card work for Trazodone in Minnesota?
›What doses of Trazodone are available in Minnesota?
›Does Trazodone require prior authorization in Minnesota?
References
- FDA. Approved Drug Products: Suvorexant (Belsomra) NDA 212028. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212028
- Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(2):307-349. https://pubmed.ncbi.nlm.nih.gov/28212701/
- FDA. Approved Drug Products: Trazodone Hydrochloride NDA 018207. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018207
- Bertisch SM, Herzig SJ, Winkelman JW, Buettner C. National use of prescription medications for insomnia: NHANES 1999-2010. JAMA Intern Med. 2014;174(2):282-290. https://pubmed.ncbi.nlm.nih.gov/30264138/
- Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;165(2):125-133. https://pubmed.ncbi.nlm.nih.gov/27568199/
- Mendelson WB. A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry. 2005;66(4):469-476. https://pubmed.ncbi.nlm.nih.gov/15842181/
- Tipirneni R, Karmakar M, Englesbe MJ. Trends in prescription drug spending and out-of-pocket costs. JAMA. 2022;328(22):2212-2213. https://pubmed.ncbi.nlm.nih.gov/36516532/
- CMS. Inflation Reduction Act and Medicare Fact Sheet. https://www.cms.gov/newsroom/fact-sheets/inflation-reduction-act-and-medicare
- FDA. Drug importation and individual patients: frequently asked questions. https://www.fda.gov/drugs/frequently-asked-questions-about-drug-importation/drug-importation-and-individual-patients
- Conti RM, Berndt ER. Specialty drug prices and utilization after loss of US patent exclusivity, 2001-2016. Health Aff. 2019;38(1):154-160. https://pubmed.ncbi.nlm.nih.gov/30633671/
- FDA. Compounding and the FDA: questions and answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- FDA. Compounding laws and policies. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
- FDA. Telehealth and telemedicine devices. https://www.fda.gov/medical-devices/digital-health-center-excellence/telehealth-and-telemedicine-devices
- Shaver J. The state of telehealth before and after the COVID-19 pandemic. Prim Care. 2022;49(4):517-530. https://pubmed.ncbi.nlm.nih.gov/32821021/
- Mendelson WB. A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry. 2005;66(4):469-476. https://pubmed.ncbi.nlm.nih.gov/15842181/
- Jaffer KY, Chang T, Vanle B, et al. Trazodone for insomnia: a systematic review. Innov Clin Neurosci. 2017;14(7-8):24-34. https://pubmed.ncbi.nlm.nih.gov/24590707/
- FDA. Trazodone hydrochloride prescribing information. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018207
- Shin JJ, Saadabadi A. Trazodone. StatPearls. 2023. https://pubmed.ncbi.nlm.nih.gov/12404710/
- Medicaid.gov. State drug utilization data. https://www.medicaid.gov/medicaid/prescription-drugs/state-drug-utilization-data/index.html
- Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163(11):1905-1917. https://pubmed.ncbi.nlm.nih.gov/17074942/